Ocugen (OCGN) Enterprise Value (QoQ) (2014 - 2024)
Ocugen (OCGN) Enterprise Value (QoQ) (2014 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Ocugen |
411.07 Mn |
411.07 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2024 |
40.54% |
| Mar 31, 2024 |
33.10% |
| Dec 31, 2023 |
26.21% |
| Sep 30, 2023 |
24.23% |
| Jun 30, 2023 |
8.01% |
| Mar 31, 2023 |
15.63% |
| Dec 31, 2022 |
10.50% |
| Sep 30, 2022 |
11.65% |
| Jun 30, 2022 |
11.38% |
| Mar 31, 2022 |
-36.66% |
| Dec 31, 2021 |
11.54% |
| Sep 30, 2021 |
7.17% |
| Jun 30, 2021 |
-158.18% |
| Mar 31, 2021 |
-86.33% |
| Dec 31, 2020 |
-25.82% |
| Sep 30, 2020 |
-27.65% |
| Jun 30, 2020 |
-368.78% |
| Mar 31, 2020 |
57.11% |
| Dec 31, 2019 |
51.35% |
| Sep 30, 2019 |
-2,155.16% |
